Xtant Medical Holdings XTNT EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Xtant Medical Holdings’s reported figures.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xtant Medical Holdings's EBITDA?
- Xtant Medical Holdings (XTNT) reported EBITDA of -$2.39M in Q1 2026.
- How has Xtant Medical Holdings's EBITDA changed year-over-year?
- Xtant Medical Holdings's EBITDA decreased by 211.8% year-over-year, from $2.14M to -$2.39M.
- What is the long-term trend for Xtant Medical Holdings's EBITDA?
- Over 4 years (2021 to 2025), Xtant Medical Holdings's EBITDA has grown at a 58.2% compound annual growth rate (CAGR), from -$2.52M to $15.77M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.